These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26273636)

  • 1. Elevated Serum Levels of Soluble CD30 in Ankylosing Spondylitis Patients and Its Association with Disease Severity-Related Parameters.
    Gao R; Sun W; Chen Y; Su Y; Wang C; Dong L
    Biomed Res Int; 2015; 2015():617282. PubMed ID: 26273636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.
    Chen Y; Sun W; Li S; Ni J; Su Y; Wang C; Luo X; Tu W; Shen G; Gong F; Zheng F; Dong L
    Clin Exp Rheumatol; 2015; 33(2):187-94. PubMed ID: 25602579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies.
    Cardiel MH; Londoño JD; Gutiérrez E; Pacheco-Tena C; Vázquez-Mellado J; Burgos-Vargas R
    Clin Exp Rheumatol; 2003; 21(4):451-8. PubMed ID: 12942696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care.
    Park SH; Choe JY; Kim SK; Lee H; Castrejón I; Pincus T
    J Clin Rheumatol; 2015 Sep; 21(6):300-4. PubMed ID: 26308349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis].
    Grazio S; Grubisić F; Nemcić T; Matijević V; Skala H
    Reumatizam; 2009; 56(2):63-76. PubMed ID: 20429263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Intercellular Adhesion Molecule-1, -2, -3 Plasma Levels and Disease Activity of Ankylosing Spondylitis in the Chinese Han Population.
    Liu R; Yue Z; Peng X; Wang X; Feng Z; Wan L
    Spine (Phila Pa 1976); 2016 May; 41(10):E618-24. PubMed ID: 26641849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S).
    Zochling J
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S47-58. PubMed ID: 22588768
    [No Abstract]   [Full Text] [Related]  

  • 8. The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validity.
    Waldner A; Cronstedt H; Stenström CH
    Scand J Rheumatol Suppl; 1999; 111():10-6. PubMed ID: 10503554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity.
    Cronstedt H; Waldner A; Stenström CH
    Scand J Rheumatol Suppl; 1999; 111():1-9. PubMed ID: 10503553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index in Turkish patients with ankylosing spondylitis: relationship with disease activity and quality of life.
    Zahiroglu Y; Ulus Y; Akyol Y; Tander B; Durmus D; Bilgici A; Kuru O
    Int J Rheum Dis; 2014 Feb; 17(2):173-80. PubMed ID: 24576273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is disease severity in ankylosing spondylitis genetically determined?
    Hamersma J; Cardon LR; Bradbury L; Brophy S; van der Horst-Bruinsma I; Calin A; Brown MA
    Arthritis Rheum; 2001 Jun; 44(6):1396-400. PubMed ID: 11407700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Scoring of disease activity using BASDAI and ASDAS method in ankylosing spondylitis].
    Bobek D; Zagar I; Kovač-Durmiš K; Perić P; Ćurković B; Babić-Naglić Ð
    Reumatizam; 2012; 59(1):5-10. PubMed ID: 25486721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.
    Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
    J Rheumatol; 1999 Apr; 26(4):961-5. PubMed ID: 10229428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum procalcitonin levels in patients with ankylosing spondylitis.
    Ozmen M; Oktay E; Tarhan EF; Aslan O; Oflazoglu U; Koseoglu MH
    Int J Rheum Dis; 2016 May; 19(5):500-5. PubMed ID: 24798190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
    Kim HR; Lee SH; Kim HY
    Rheumatology (Oxford); 2006 Oct; 45(10):1197-200. PubMed ID: 16567356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
    Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L;
    Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study).
    Sellas I Fernandez A; Juanola Roura X; Alonso Ruiz A; Rosas J; Medina Luezas J; Collantes Estevez E; Abad Hernández MÁ; Carrasco Benitez V; Fisac C
    Rheumatol Int; 2017 Nov; 37(11):1817-1823. PubMed ID: 28918450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Tunisian versions of Bath Ankylosing Spondylitis Functional Index (BASFI) and Disease Activity Index (BASDAI).
    Kchir MM; Hamdi W; Kochbati S; Azzouz D; Daoud L; Saadellaoui K; Ghannouchi MM; Kaffel D; Ben Hamida A; Zouari B
    Tunis Med; 2009 Aug; 87(8):527-30. PubMed ID: 20180357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis.
    Konsta M; Bamias G; Tektonidou MG; Christopoulos P; Iliopoulos A; Sfikakis PP
    Rheumatology (Oxford); 2013 Mar; 52(3):448-51. PubMed ID: 23204549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum levels of calprotectin (myeloid-related protein 8/14) in patients with ankylosing spondylitis and its association with disease activity and quality of life.
    Oktayoglu P; Bozkurt M; Mete N; Caglayan M; Em S; Nas K
    J Investig Med; 2014 Aug; 62(6):880-4. PubMed ID: 24922195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.